Matches in Wikidata for { <http://www.wikidata.org/entity/Q90358380> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q90358380 description "artículu científicu espublizáu en xunu de 2018" @default.
- Q90358380 description "scientific article published on 01 June 2018" @default.
- Q90358380 description "wetenschappelijk artikel" @default.
- Q90358380 description "наукова стаття, опублікована в червні 2018" @default.
- Q90358380 name "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 name "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 type Item @default.
- Q90358380 label "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 label "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 prefLabel "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 prefLabel "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 P1433 Q90358380-EB4C1149-EBA4-47F2-8EDB-E287705A954A @default.
- Q90358380 P1476 Q90358380-F7081771-38F3-482E-8561-48679BECF2E2 @default.
- Q90358380 P2093 Q90358380-00C222A6-AB1A-4D06-A710-E4916A159E46 @default.
- Q90358380 P2093 Q90358380-09A70DFD-24F4-49B4-B1BC-D802E533D8C9 @default.
- Q90358380 P2093 Q90358380-0CB47493-5D76-48DE-AA3A-FCB265395F91 @default.
- Q90358380 P2093 Q90358380-0F1AD06B-6DB3-4906-860C-9DFB88941903 @default.
- Q90358380 P2093 Q90358380-1BD00322-BDAF-4EA0-B177-0F75064162B6 @default.
- Q90358380 P2093 Q90358380-215BA4B5-9AC2-419E-B1F4-139E267A0DC4 @default.
- Q90358380 P2093 Q90358380-59F07F18-F3B3-4BD5-8973-59AE3F2AB669 @default.
- Q90358380 P2093 Q90358380-634FCE08-DC40-4623-8881-E1B824DBB788 @default.
- Q90358380 P2093 Q90358380-6E362CE0-048D-4D08-9265-B8C0C90212E8 @default.
- Q90358380 P2093 Q90358380-7766C7AD-BA66-4180-B81E-7FBC2C48E4A7 @default.
- Q90358380 P2093 Q90358380-88416958-CEB8-44A2-9A3D-17C40DE6D8D9 @default.
- Q90358380 P2093 Q90358380-8B48753B-48EE-4B15-A54A-A8968FBD577A @default.
- Q90358380 P2093 Q90358380-A9394440-E8F0-4BC3-ADCC-EB693D8AEFDE @default.
- Q90358380 P2093 Q90358380-AB4E84F9-8955-40DF-8678-0CD0E705243A @default.
- Q90358380 P2093 Q90358380-B3605499-1221-40E9-8424-BED2FC18CB86 @default.
- Q90358380 P2093 Q90358380-D2258DE8-84CD-48F7-ABD3-DB81B97C56CD @default.
- Q90358380 P2093 Q90358380-D3E227DE-B2A4-4B10-8D29-A06FDDCF928A @default.
- Q90358380 P2093 Q90358380-D978FF68-EB89-446F-A061-D9A20419E67B @default.
- Q90358380 P2093 Q90358380-E1B10042-5FCB-4A57-BC8D-78C8D85DA15F @default.
- Q90358380 P2093 Q90358380-E916FBE7-2FEC-4576-80EB-4A0BBC874804 @default.
- Q90358380 P2093 Q90358380-EAD90AA7-9757-46EF-9F68-5932AC6A4280 @default.
- Q90358380 P2093 Q90358380-EBB6F4D3-60D6-443D-A88C-CC1731BFD94D @default.
- Q90358380 P304 Q90358380-ADF97FB4-131B-46CC-8135-BECE774E4C6A @default.
- Q90358380 P31 Q90358380-A8A6E4D3-8EF2-4731-89A1-7259399FCE8F @default.
- Q90358380 P356 Q90358380-07EADDA7-95A3-43D0-A265-8BC7CDD498DA @default.
- Q90358380 P478 Q90358380-96E2B47B-DD03-49B3-97F5-4237E1A7FEA6 @default.
- Q90358380 P577 Q90358380-BF0799E1-AA55-4CD4-8741-CA3C125105A7 @default.
- Q90358380 P921 Q90358380-26571738-1F5C-4254-86A8-D94973069A70 @default.
- Q90358380 P921 Q90358380-BCB61EEC-6196-44BC-BFF7-2466A8BFE95E @default.
- Q90358380 P356 MDY149.016 @default.
- Q90358380 P1433 Q326122 @default.
- Q90358380 P1476 "FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial by GONO" @default.
- Q90358380 P2093 "A Falcone" @default.
- Q90358380 P2093 "B Borelli" @default.
- Q90358380 P2093 "C Antoniotti" @default.
- Q90358380 P2093 "C Cremolini" @default.
- Q90358380 P2093 "D Gemma" @default.
- Q90358380 P2093 "D Rossini" @default.
- Q90358380 P2093 "E Dell'Aquila" @default.
- Q90358380 P2093 "E Mori" @default.
- Q90358380 P2093 "F Bergamo" @default.
- Q90358380 P2093 "F Loupakis" @default.
- Q90358380 P2093 "F Marmorino" @default.
- Q90358380 P2093 "G Cardellino" @default.
- Q90358380 P2093 "G Fontanini" @default.
- Q90358380 P2093 "G Masi" @default.
- Q90358380 P2093 "G Tonini" @default.
- Q90358380 P2093 "L Boni" @default.
- Q90358380 P2093 "L Marcucci" @default.
- Q90358380 P2093 "L Salvatore" @default.
- Q90358380 P2093 "N Pella" @default.
- Q90358380 P2093 "S Delfanti" @default.
- Q90358380 P2093 "S Lonardi" @default.
- Q90358380 P2093 "V Ricci" @default.
- Q90358380 P304 "v106" @default.
- Q90358380 P31 Q13442814 @default.
- Q90358380 P356 "10.1093/ANNONC/MDY149.016" @default.
- Q90358380 P478 "29 Suppl 5" @default.
- Q90358380 P577 "2018-06-01T00:00:00Z" @default.
- Q90358380 P921 Q413299 @default.
- Q90358380 P921 Q42824440 @default.